Carregant...
Mass Spectrometry: A Platform for Biomarker Discovery and Validation for Alzheimer’s and Parkinson’s Diseases
Accurate, reliable, and objective biomarkers for Alzheimer’s disease (AD), Parkinson’s disease (PD), and related age-associated neurodegenerative disorders are urgently needed to assist in both diagnosis, particularly at early stages, and monitoring of disease progression. Technological advancements...
Guardat en:
| Publicat a: | J Neurochem |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6535381/ https://ncbi.nlm.nih.gov/pubmed/30474862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jnc.14635 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|